BMO Capital Cut Price Target on Abercrombie & Fitch (ANF) to $19 Following 2Q

Go back to BMO Capital Cut Price Target on Abercrombie & Fitch (ANF) to $19 Following 2Q

UBS Remains Sidelined on Abercrombie & Fitch (ANF) Following 2Q - PT to $18

August 31, 2016 9:29 AM EDT

UBS maintained a Neutral rating on Abercrombie & Fitch (NYSE: ANF), and cut the price target to $18.00 (from $22.00), following the company's 2Q earnings report. UBS lowered FY16 EPS estimates to 0.67 (from $0.74), compared to the Street's $0.80. The cut is based on SSS.

Analyst Michael Binetti... More

Stifel Downgrades Abercrombie & Fitch (ANF) to Hold

August 31, 2016 6:32 AM EDT

Stifel downgraded Abercrombie & Fitch (NYSE: ANF) from Buy to Hold, citing a lack of visibiilty for near-term improvement.

Analyst Richard Jaffe commented, "Our positive thesis on ANF shares has been that a more thoughtful, on-brand and balanced merchandise assortment combined with a favorable response to the significant marketing investments would drive 2H comp improvement and expense leverage.... More

Standpoint Research Upgrades Abercrombie & Fitch (ANF) to Buy

August 30, 2016 2:18 PM EDT

Standpoint Research upgraded Abercrombie & Fitch (NYSE: ANF) from Hold to Buy.

For an analyst ratings summary and ratings history on Abercrombie & Fitch click here. For more ratings news on Abercrombie & Fitch click here.

Shares of Abercrombie & Fitch closed at $22.95 yesterday.

... More

Mizuho Securities Cuts Price Target on Abercrombie & Fitch (ANF) Following 2Q Miss

August 30, 2016 1:21 PM EDT

Mizuho Securities maintained a Neutral rating on Abercrombie & Fitch (NYSE: ANF), and cut the price target to $20.00 (from $23.00), following the company's 2Q earnings report. ANF reported EPS of $(0.25), missing the Streets $(0.20) estimate.

Analyst Betty Chen commented, "We are lowering our estimates... More

Unusual 11 Mid-Day Movers 8/30: (RIGL) (KPTI) (RBA) Higher; (ANF) (CBK) (GIII) Lower

August 30, 2016 12:56 PM EDT

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) 50.8% HIGHER; announced that fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, met the primary endpoint in the first of two double-blind studies in the FIT Phase 3 clinical program for the treatment of adult chronic/persistent immune thrombocytopenia (ITP). The study (n=76) showed that 18% of patients receiving fostamatinib achieved a stable platelet response compared to none receiving a placebo control (p=0.0261).

Abercrombie & Fitch (NYSE: ANF) 28.5% LOWER; reported Q2 EPS of ($0.25), $0.05 worse than the analyst estimate of... More

Pre-Open Stock Movers 08/30: (RIGL) (RBA) (MDLZ) Higher; (GIII) (ANF) (HSY) Lower (more...)

August 30, 2016 9:07 AM EDT

Today's Pre-Open Stock Movers

Bonanza Creek Energy, Inc. (NYSE: BCEI) 24.2% HIGHER; announces that it has been notified by The New York Stock Exchange (NYSE) that it is no longer in compliance with certain continued listing... More

Abercrombie & Fitch's (ANF) Flagship, Tourist Locations Pressured Q2 Results Amid Light Traffic - Stifel

August 30, 2016 8:40 AM EDT

Stifel offered some initial takeaways from Abercrombie & Fitch's (NYSE: ANF) Q2 results and revised outlook. Stifel rates ANF at Buy... More

Wall St. weighed by Apple but banks shine on

August 30, 2016 7:40 AM EDT

By Rodrigo Campos

NEW YORK (Reuters) - Apple Inc was the largest weight on U.S. stock indexes on Tuesday after antitrust regulators ordered the company to pay about $14.5 billion in back taxes to the Irish government, but gains in bank shares partly offset the decline.

The S&P 500 fell for the fourth time in five sessions, but was still within 1 percent of its record closing high set earlier this month. Cyclical sectors, which are expected to perform better in an expanding economy, have taken the lead in the past few weeks as economic data paints a... More

Abercrombie & Fitch (ANF) Misses Q2 EPS by 5c

August 30, 2016 7:32 AM EDT

Abercrombie & Fitch (NYSE: ANF) reported Q2 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $783.2 million versus the consensus estimate of $782.1 million.

Comps fell 4 percent, versus an estimated 3.8 percent drop.

Fiscal 2016 Outlook

For fiscal 2016, the company now... More

Trading Radar for 8/30: Abercrombie & Fitch (ANF), Palo Alto Networks (PANW), Veeva Systems (VEEV) Report

August 29, 2016 2:58 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
9:00am EDT

Case-Shiller 20-city Index - Street sees 5.1%

Earnings:

Abercrombie & Fitch (NYSE: ANF) - consensus loss... More

Abercrombie & Fitch (ANF) puts more active than calls into Q2 and outlook

August 29, 2016 2:40 PM EDT

Abercrombie & Fitch (NYSE: ANF) September 18 and 21 puts are active on total put volume of 25K contracts (18K calls) into the expected release of Q2 results on August 30. September weekly call option implied volatility is at 140, September is at 71, October is at 49; compared to its 52-week range of 33 to 75.

... More